Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Luminex magnetic carboxylated microsphere beads, or equivalent

Closed
75F40126SSN134073Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413
New
DIBBS
TEST KIT, CHLAMYDIA TRA
Solicitation # SPE2DS-26-T-423P
Solicitation SPE2DS-26-T-423P, issued by the DLA Troop Support Medical Supply Chain, is a request for quotes for one test kit for the detection of Chlamydia trachomatis, identified by NSN 6550-01-725-3600. The kit is designed for in vitro diagnostic use to perform qualitative direct immunofluorescence tests on human urogenital and ophthalmic specimens, as well as for confirming Chlamydia in cell culture. Each kit must provide materials for 50 tests and include two positive control slides, mounting fluid, Chlamydia test reagent, and instructions for use. The required delivery date is September 14, 2026, with the place of performance and delivery located in San Antonio, Texas. The procurement falls under NAICS code 325413 and is subject to destination inspection and acceptance. Packaging must adhere to commercial standards, MIL-STD-2073-1E, and RP001, while marking must comply with Medical Marking Standard No. 1. The contract incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and the Hazard Communication Standard for hazardous materials. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system. Quotes must be submitted via the DIBBS portal by September 16, 2026, and the award may be processed through an automated system, with a price evaluation preference applied to HUBZone concerns.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

Show more

The U.S. Food and Drug Administration’s Office of Acquisitions and Grants Services, under the Department of Health and Human Services, issued a Sources Sought Notice to gather market information for magnetic carboxylated microsphere beads, including Luminex-compatible products or their equivalents. This notice, identified by solicitation number 75F40126SSN134073 and posted on April 29, 2026, with responses due by 3:00 p.m. Central Time on May 6, 2026, is strictly for market research and will not result in any contract award. Respondents must provide a detailed capability statement through email to Suzanne Martella at suzanne.martella@fda.hhs.gov, including business information, technical specifications, past performance, manufacturing details, and descriptive literature, with no weblinks permitted. The notice requires delivery of products within 60 days of any future award to the FDA/CBER facility in Silver Spring, MD, and mandates compliance with Buy American and Made in America statutes. Detailed product requirements include carboxylated surfaces for EDC/NHS conjugation, superparamagnetic properties, distinct fluorescent signatures compatible with two-laser flow cytometry, minimum 20 distinct bead regions, lot-to-lot consistency, freedom from contamination and aggregation, and a six-month shelf life at time of delivery. Respondents must disclose their Unique Entity ID, size status, and country of origin for the product; small businesses, including VOSB, SDVOSB, HUBZone SB, SDB, and WOSB, are encouraged to respond, and large businesses must indicate whether subcontracting opportunities for small businesses are available. The NAICS code for this effort is 325413, and no formal contract clauses, packaging guidelines, inspection procedures, evaluation factors, or contract value estimates are included. All submissions must be self-contained and fully responsive to technical and commercial specifications without reliance on external links.

General Info

FDA seeks market info on Luminex-compatible carboxylated magnetic beads for CBER, due May 6, 2026, with Buy American compliance required.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

SSN+75F40126SSN134073.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts

Full Description

Show more

See attached Sources Sought Notice (SSN) for Luminex, or equal, magnetic carboxylated microsphere beads.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS